News As patents expire, fampridine is cleared for NHS use in MS Several years after other UK nations, people living with multiple sclerosis in England are finally able to get NHS treatment with fampridine.
News FDA issues warning letters to five unapproved GLP-1 websites In a handful of strongly-worded warning letters, the FDA is cracking down on sales of unapproved peptides - even if they're labelled for research.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.